The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...
The effects that a pause may have on your body may depend on why you're taking the medication in the first place.
The investigational therapy works to impede the expression of genes that cause the body to store fat as a potential treatment ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...
One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback